Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tenry Pharma is a leading Chinese biopharmaceutical company focused on the development and commercialization of innovative therapies in dermatology, oncology, and wound healing. The company leverages its proprietary technology platforms for topical drug delivery and recombinant protein engineering to address significant unmet medical needs. Tenry Pharma's portfolio includes several marketed products, such as recombinant human growth factors for wound repair, and a diverse pipeline of clinical-stage candidates. With integrated R&D and GMP-certified manufacturing capabilities, the company aims to provide high-quality, affordable medicines to patients globally. Tenry is headquartered in Shanghai and maintains a strong presence in the domestic Chinese market while expanding its international reach. The company continues to invest in novel small molecules and biologics to strengthen its position in the specialty pharma sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tenry Pharma.